Last updated on November 2019

A Phase III Study of Efficacy and Safety of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.


Find a site near you

Start Over

Novartis Investigative Site

Mannheim, Germany
7.27miles
  Connect »

Novartis Investigative Site

Heidelberg, Germany
9.15miles
  Connect »